MedTrace Logo

Laser Treatment for Facial and Neck Rejuvenation

NCT05808842 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-04-11

No results posted yet for this study

Summary

To assess the efficacy, safety, and patient satisfaction associated with the treatment of the face and neck with the 2,910nm mid-infrared UltraClear Laser System using both superficial epidermal ablation and deep ablative and coagulative capabilities in the dermis for rejuvenation of photodamaged skin. Additionally, this study will assess the additive value of a post-treatment skincare regimen consisting of a serum and cream containing red deer umbilical cord lining mesenchymal stem cell conditioned media for faster healing and more robust rejuvenation.

Conditions

  • Face Rejuvenation
  • Neck Rejuvenation

Interventions

OTHER

CeraVe

* CeraVe gentle facial cleanser (CeraVe; New York, NY) to be used morning and evening * CeraVe lotion (CeraVe; New York, NY) to be used morning and evening, reapply as needed for dry skin * A mineral CeraVe sunscreen (CeraVe; New York, NY) to be applied in the morning and reapplied every 2 hours if going outside

OTHER

CeraVe and Calecim

* CeraVe gentle facial cleanser (CeraVe; New York, NY) to be used morning and evening * Calecim® Professional Serum (CellResearch Corporation; Singapore) to be used morning and evening * Calecim® Restorative Hydration Cream (CellResearch Corporation; Singapore) to be used morning and evening, reapply as needed for dry skin * A mineral CeraVe sunscreen (CeraVe; New York, NY) to be applied in the morning and reapplied every 2 hours if going outside

Sponsors & Collaborators

  • Acclaro Corporation

    collaborator UNKNOWN

  • Goldman, Butterwick, Fitzpatrick and Groff

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-03
Primary Completion
2024-02-28
Completion
2024-02-28
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05808842 on ClinicalTrials.gov